Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 459

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Behavioral Therapies for Drug Abuse

Open access
Carroll, Kathleen M., Onken, Lisa S.·2005·American Journal of Psychiatry

Abstract

The past three decades have been marked by tremendous progress in behavioral therapies for drug abuse and dependence, as well as advances in the conceptualization of approaches to development of behavioral therapies. Cognitive behavior therapy, contingency management, couples and family therapy, and a variety of other types of behavioral treatment have been shown to be potent interventions for several forms of drug addiction, and scientific progress has also been greatly facilitated by the articulation of a systematic approach to the development, evaluation, and dissemination of behavioral therapies. The authors review recent progress in strategies for the development of behavioral therapies for drug and alcohol abuse and dependence and discuss the range of effective behavioral therapies that are currently available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.162.8.1452

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 74

  1. Sargent S: The treatment of depressive states. Int J Neurol 1967; 6:53–64
  2. Agras WS, Chapin HN, Oliveau DC: The natural history of phobia. Arch Gen Psychiatry 1972; 26:315–317 · DOI
  3. Marks IM: New approaches to the treatment of obsessive-compulsive disorders. J Nerv Ment Dis 1973; 156:420–426 · DOI
  4. Elkin I, Pilkonis PA, Docherty JP, Sotsky SM: Conceptual and methodologic issues in comparative studies of psychotherapy and pharmacotherapy, I: active ingredients and mechanisms of change. Am J Psychiatry 1988; 145:909–917 · DOI
  5. Elkin I, Pilkonis PA, Docherty JP, Sotsky SM: Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy, II: nature and timing of treatment effects. Am J Psychiatry 1988; 145:1070–1076 · DOI
  6. Woody GE, Luborsky L, McLellan AT, O’Brien CP, Beck AT, Blaine JD, Herman L, Hole A: Psychotherapy for opiate addicts: does it help? Arch Gen Psychiatry 1983; 40:639–645 · DOI · Paper page
  7. Onken LS, Blaine JD: Psychotherapy and counseling research in drug abuse treatment: questions, problems, and solutions. NIDA Research Monogr 1990; 104:1–8 · DOI
  8. Kang SY, Kleinman PH, Woody GE, Millman RB, Todd TC, Kemp J, Lipton DS: Outcomes for cocaine abusers after once-a-week psychosocial therapy. Am J Psychiatry 1991; 148:630–635 · DOI
  9. Kazdin AE: Comparative outcome studies in psychotherapy: methodological issues and strategies. J Consult Clin Psychol 1986; 54:95–105 · DOI · Paper page
  10. Stitzer ML, Bickel WK, Bigelow GE, Liebson IA: Effect of methadone dose contingencies on urinalysis test results of polydrug abusing methadone maintenance patients. Drug Alcohol Depend 1986; 18:341–348 · DOI
  11. Stitzer ML, Iguchi MY, Felch LJ: Contingent take-home incentives: effects on drug use of methadone maintenance patients. J Consult Clin Psychol 1992; 60:927–934 · DOI · Paper page
  12. Dolan MP, Black JL, Penk WE, Rabinowitz R, DeFord HA: Contracting for treatment termination to reduce illicit drug use among methadone maintenance treatment failures. J Consult Clin Psychol 1985; 53:549–551 · DOI
  13. Kidorf M, Stitzer ML: Contingent use of take-homes and split-dosing to reduce illicit drug use of methadone patients. Behav Ther 1996; 27:41–51 · DOI
  14. Iguchi MY, Stitzer ML, Bigelow GE, Liebson IA: Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug Alcohol Depend 1988; 22:1–7 · DOI
  15. Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantona RL: Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J Consult Clin Psychol 2000; 68:64–72 · DOI · Paper page
  16. Higgins ST, Badger GJ, Budney AJ: Initial abstinence and success in achieving longer term cocaine abstinence. Exp Clin Psychopharmacol 2000; 8:377–386 · DOI · Paper page
  17. Bickel WK, Amass L, Higgins ST, Badger GJ, Esch RA: Effects of adding behavioral treatment to opioid detoxification with buprenorphine. J Consult Clin Psychol 1997; 65:803–810 · DOI · Paper page
  18. Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, Rawson RA, Ling W: Smoking cessation in methadone maintenance. Addiction 2002; 97:1317–1328 · DOI · Paper page
  19. Budney AJ, Higgins ST, Radonovich KJ, Novy PL: Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 2000; 68:1051–1061 · DOI · Paper page
  20. Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR: Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend 1999; 54:127–135 · DOI · Paper page
  21. Carroll KM, Ball SA, Nich C, O’Connor PG, Eagan D, Frankforter TL, Triffleman EG, Shi J, Rounsaville BJ: Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry 2001; 58:755–761 · DOI · Paper page
  22. Carroll KM, Sinha R, Nich C, Babuscio T, Rounsaville BJ: Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude. Exp Clin Psychopharmacol 2002; 10:54–63 · DOI
  23. Iguchi MY, Belding MA, Morral AR, Lamb RJ, Husband SD: Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. J Consult Clin Psychol 1997; 65:421–428 · doi:10.1037/0022-006x.65.3.421 · Paper page
  24. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL: Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry 1996; 53:409–415 · DOI · Paper page
  25. Silverman K, Wong CJ, Umbricht-Schneiter A, Montoya ID, Schuster CR, Preston KL: Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. J Consult Clin Psychol 1998; 66:811–824 · doi:10.1037//0022-006x.66.5.811 · Paper page
  26. Silverman K, Wong CJ, Higgins ST, Brooner RK, Montoya ID, Contoreggi C, Umbricht-Schneiter A, Schuster CR, Preston KL: Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend 1996; 41:157–165 · DOI
  27. Silverman K, Svikis DS, Robles E, Stitzer ML, Bigelow GE: A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Exp Clin Psychopharmacol 2001; 9:14–23 · DOI · Paper page
  28. Silverman K, Svikis DS, Wong CJ, Hampton J, Stitzer ML, Bigelow GE: A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes. Exp Clin Psychopharmacol 2002; 10:228–240 · DOI
  29. Petry NM, Martin B, Cooney JL, Kranzler HR: Give them prizes and they will come: contingency management treatment of alcohol dependence. J Consult Clin Psychol 2000; 68:250–257 · DOI · Paper page
  30. Petry NM, Martin B: Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J Consult Clin Psychol 2002; 70:398–405 · DOI · Paper page
  31. Petry NM, Tedford J, Austin M, Nich C, Carroll KM, Rounsaville BJ: Prize reinforcement contingency management for treating cocaine abusers: how low can we go, and with whom? Addiction 2004; 99:349–360 · DOI · Paper page
  32. Irvin JE, Bowers CA, Dunn ME, Wong MC: Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol 1999; 67:563–570 · doi:10.1037//0022-006x.67.4.563 · Paper page
  33. Maude-Griffin PM, Hohenstein JM, Humfleet GL, Reilly PM, Tusel DJ, Hall SM: Superior efficacy of cognitive-behavioral therapy for crack cocaine abusers: main and matching effects. J Consult Clin Psychol 1998; 66:832–837 · doi:10.1037//0022-006x.66.5.832 · Paper page
  34. Rohsenow DJ, Monti PM, Martin RA, Michalec E, Abrams DB: Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes. J Consult Clin Psychol 2000; 68:515–520 · doi:10.1037//0022-006x.68.3.515
  35. McKay JR, Alterman AI, Cacciola JS, Rutherford MJ, O’Brien CP, Koppenhaver J: Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence. J Consult Clin Psychol 1997; 65:778–788 · DOI
  36. Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow PM, Bisighini RM, Gawin FH: Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 1994; 51:177–197 · DOI · Paper page
  37. Carroll KM, Rounsaville BJ, Gawin FH: A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. Am J Drug Alcohol Abuse 1991; 17:229–247 · DOI · Paper page
  38. Rosenblum A, Magura S, Palij M, Foote J, Handlesman L, Stimmel B: Enhanced treatment outcomes for cocaine-using methadone patients. Drug Alcohol Depend 1999; 54:207–218 · DOI
  39. Carroll KM, Nich C, Ball SA, McCance-Katz E, Rounsaville BJ: Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998; 93:713–728 · DOI · Paper page
  40. Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ: Efficacy of disulfiram and cognitive-behavioral therapy in cocaine-dependent outpatients: a randomized placebo controlled trial. Arch Gen Psychiatry 2004; 64:264–272 · DOI · Paper page
  41. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin FH: One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994; 51:989–997 · DOI · Paper page
  42. Carroll KM, Nich C, Ball SA, McCance-Katz EF, Frankforter TF, Rounsaville BJ: One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol abusers: sustained effects of treatment. Addiction 2000; 95:1335–1349 · DOI · Paper page
  43. Hollon SD, Shelton RC, Davis DD: Cognitive therapy for depression: conceptual issues and clinical efficacy. J Consult Clin Psychol 1993; 61:270–275 · DOI
  44. Rawson RA, Huber A, McCann MJ, Shoptaw S, Farabee D, Reiber C, Ling W: A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance for cocaine dependence. Arch Gen Psychiatry 2002; 59:817–824 · DOI · Paper page
  45. Epstein DE, Hawkins WE, Covi L, Umbricht A, Preston KL: Cognitive behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol Addict Behav 2003; 17:73–82 · DOI
  46. Dunn C, Deroo I, Rivara FP: The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001; 96:1725–1742 · DOI · Paper page
  47. Stephens R, Roffman RA, Curtin L: Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol 2000; 68:898–908 · DOI · Paper page
  48. Carey MP, Maisto SA, Kalichman SC, Forsythe AD, Wright EM, Johnson BT: Enhancing motivation to reduce the risk of HIV infection for economically disadvantaged urban women. J Consult Clin Psychol 1997; 65:531–541 · DOI
  49. Carey MP, Braaten LS, Maisto SA, Gleason JR, Forsythe AD, Durant LE, Jaworski BC: Using information, motivational enhancement, and skills training to reduce the risk of HIV infection for low-income urban women: a second randomized clinical trial. Health Psychol 2000; 19:3–11 · DOI · Paper page
  50. Miller WR, Yahne CE, Tonigan JS: Motivational interviewing in drug abuse services: a randomized trial. J Consult Clin Psychol 2003; 71:754–763 · DOI · Paper page
  51. Donovan DM, Rosengren DB, Downey L, Cox GC, Sloan KL: Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction 2001; 96:1149–1160 · DOI
  52. Baker A, Lewin T, Reichler H, Clancy R, Carr V, Garret R, Sly K, Devir H, Terry M: Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatr Scand 2002; 106:233–240 · DOI
  53. Henggeler SW, Pickrel SG, Brondino MJ, Crouch JL: Eliminating (almost) treatment dropout of substance abusing or dependent delinquents through home-based multisystemic therapy. Am J Psychiatry 1996; 153:427–428 · DOI · Paper page
  54. Liddle HA, Dakof GA, Parker K, Diamond GS, Barrett K, Tejeda M: Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. Am J Drug Alcohol Abuse 2001; 27:651–688 · DOI · Paper page
  55. Stanton MD, Shadish WR: Outcome, attrition, and family-couples treatment for drug abuse: a meta-analysis and review of the controlled, comparative studies. Psychol Bull 1997; 122:170–191 · doi:10.1037//0033-2909.122.2.170 · Paper page
  56. Liddle HA, Dakof G: Efficacy of family therapy for drug abuse: promising but not definitive. J Marital Fam Ther 1995; 21:511–543 · DOI · Paper page
  57. Waldron HB: Adolescent substance abuse and family therapy outcome: a review of randomized trials. Adv Clin Child Psychol 1997; 19:199–234 · DOI
  58. Deas D, Thomas SE: An overview of controlled studies of adolescent substance abuse treatment. Am J Addict 2001; 10:178–189 · DOI · Paper page
  59. Waldron HB, Slesnick N, Brody JL, Turner CW, Peterson TR: Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol 2001; 69:802–813 · DOI
  60. Fals-Stewart W, O’Farrell TJ, Birchler GR: Behavioral couples therapy for male substance-abusing patients: a cost outcomes analysis. J Consult Clin Psychol 1997; 65:789–802 · doi:10.1037//0022-006x.65.5.789
  61. Fals-Stewart W, O’Farrell TJ, Birchler GR: Behavioral couples therapy for male methadone patients: effects on drug-using behavior and relationship adjustment. Behav Ther 2001; 32:391–411 · DOI
  62. Fals-Stewart W, O’Farrell TJ: Behavioral family counseling and naltrexone for male opioid-dependent patients. J Consult Clin Psychol 2003; 71:432–442 · DOI · Paper page
  63. Kelley ML, Fals-Stewart W: Couples- versus individual-based therapy for alcohol and drug abuse: effects on children’s psychosocial functioning. J Consult Clin Psychol 2002; 70:417–427 · DOI
  64. Azrin NH, Donohue B, Besalel VA, Kogan ES, Acierno R: Youth drug abuse treatment: a controlled outcome study. J Child Adolesc Subst Abuse 1994; 3:1–16 · DOI · Paper page
  65. Henggeler SW, Melton GB, Smith LA: Family preservation using multisystemic therapy: an effective alternative to incarcerating serious juvenile offenders. J Consult Clin Psychol 1992; 60:953–961 · doi:10.1037//0022-006x.60.6.953 · Paper page
  66. Huey SJ, Henggeler SW, Brondino MJ, Pickrel SG: Mechanisms of change in multisystemic therapy: reducing delinquent behavior through therapist adherence and improved family and peer functioning. J Consult Clin Psychol 2000; 68:451–467 · DOI
  67. Henggeler SW, Clingempeel WG, Brondino MJ, Pickrel SG: Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry 2002; 41:868–874 · DOI · Paper page
  68. Szapocznik J, Perez-Vidal A, Brickman AL, Foote FH, Santisteban DA, Hervis O, Kurtines WM: Engaging adolescent drug abusers and their families in treatment: a strategic structural systems approach. J Consult Clin Psychol 1988; 56:552–557 · DOI · Paper page
  69. Szapocznik J, Kurtines WM, Foote FH, Perez-Vidal A, Hervis O: Conjoint versus one-person family therapy: some evidence for the effectiveness of conducting family therapy through one person. J Consult Clin Psychol 1986; 54:395–397 · doi:10.1037/0022-006x.54.3.395 · Paper page
  70. Crits-Christoph P, Siqueland L, Blaine JD, Frank A, Luborsky L, Onken LS, Muenz L, Thase ME, Weiss RD, Gastfriend DR, Woody G, Barber JP, Butler S, Dale D, Salloum I, Bishop S, Najavits L, Lis J: Psychosocial treatments for cocaine dependence: results of the National Institute on Drug Abuse Collaborative Cocaine Study. Arch Gen Psychiatry 1999; 56:495–502
  71. Woody GE, Gallop R, Luborsky L, Blaine JD, Frank A, Salloum IM, Gastfriend DR, Crits-Christoph P (Cocaine Psychotherapy Study Group): HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study. J Acquir Immune Defic Syndr 2003; 33:82–87 · DOI
  72. Sorensen JL, Copeland AL: Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend 2000; 59:17–31 · DOI · Paper page
  73. Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J: A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol 2003; 22:223–228 · DOI · Paper page
  74. Avants SK, Margolin A, Usubiaga MH, Doebrick C: Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of harm reduction group therapy. J Subst Abuse Treat 2004; 26:67–78 · DOI

Cited by

See all 459

Metadata

Authors
Carroll, K. M., & Onken, L. S.
Venue
American Journal of Psychiatry
Published
2005-08-01
Volume
162
Issue
8
Pages
1452-1460
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2128626847
Cited by
459
References
16
FWCI
10.47
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Behavioral Therapies for Drug Abuse. https://app.cochat.ai/papers/10.1176/appi.ajp.162.8.1452
The paper
Carroll, K. M., & Onken, L. S. (2005). Behavioral Therapies for Drug Abuse. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.162.8.1452

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.